[Adrenergic hyperactivity in tetanus].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D005260:Female; D006801:Humans; D013564:Sympathetic Nervous System / Q000503:physiopathology*; D013742:Tetanus / Q000188:drug therapy / Q000503:physiopathology*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists
Adrenerg hyperaktivitet vid tetanus.